Literature DB >> 20511440

Orthopaedic manifestations of neurofibromatosis type 1.

David S Feldman1, Charles Jordan, Lauren Fonseca.   

Abstract

Neurofibromatosis type 1 (NF-1) is an autosomal dominant disease that affects 1 in 3,000 persons worldwide. Café-au-lait macules and peripheral nerve sheath tumors (ie, neurofibromas) are the most commonly recognized manifestations of NF-1. However, NF-1 affects multiple organ systems, and a multidisciplinary approach to treatment is required. Management of the orthopaedic manifestations of NF-1 is often difficult. The most complex manifestations are scoliosis (dystrophic and nondystrophic), congenital pseudarthrosis of the tibia, and problems related to soft-tissue tumors. Metabolic bone disease is common; many patients are frankly osteopenic, which further complicates treatment. Dystrophic scoliosis, which may be caused by either bony dysplasia or intraspinal pathology, is characterized by early presentation and rapid progression. Pseudarthrosis is common even after instrumented fusion. Nondystrophic scoliosis tends to behave like adolescent idiopathic scoliosis, although it may present earlier and is associated with a higher rate of pseudarthrosis. Congenital pseudarthrosis of the tibia is a long-bone dysplasia that afflicts patients with NF-1. Management of this osseous deformity is challenging. Failure to achieve union and refracture are common.

Entities:  

Mesh:

Year:  2010        PMID: 20511440     DOI: 10.5435/00124635-201006000-00007

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  21 in total

1.  Posterior Spinal Reconstruction with Pedicle Screws, Multiple Iliac Screws and Wisconsin Spinal Wires in a Patient with Neurofibromatosis Scoliosis: A Case Report.

Authors:  Woong-Beom Kim; Young-Seop Park; Jong-Hwa Park; Seung-Jae Hyun
Journal:  Korean J Spine       Date:  2015-09-30

2.  "Bone Morphogenic Protein augmentation for long bone healing" response to "Clinical need for bone morphogenetic protein".

Authors:  Gopal Shankar Krishnakumar; Alice Roffi; Davide Reale; Elizaveta Kon; Giuseppe Filardo
Journal:  Int Orthop       Date:  2017-09-03       Impact factor: 3.075

3.  Pediatric scoliosis.

Authors:  Fred Mo; Matthew E Cunningham
Journal:  Curr Rev Musculoskelet Med       Date:  2011-12

4.  AN ADJUNCTIVE USE OF ASFOTASE ALFA AND ZOLEDRONIC ACID AFTER SPINAL SURGERY IN NEUROFIBROMATOSIS TYPE 1 RELATED DYSTROPHIC SCOLIOSIS.

Authors:  Tasma Harindhanavudhi; Takashi Takahashi; Anna Petryk; David W Polly
Journal:  AACE Clin Case Rep       Date:  2020-08-06

5.  Identifying Bone Matrix Impairments in a Mouse Model of Neurofibromatosis Type 1 (NF1) by Clinically Translatable Techniques.

Authors:  Rafay Ahmed; Sasidhar Uppuganti; Shrey Derasari; Joshua Meyer; Jacquelyn S Pennings; Florent Elefteriou; Jeffry S Nyman
Journal:  J Bone Miner Res       Date:  2022-07-12       Impact factor: 6.390

6.  Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.

Authors:  Joachim Horn; Harald Steen; Terje Terjesen
Journal:  J Child Orthop       Date:  2013-01-18       Impact factor: 1.548

Review 7.  Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia.

Authors:  Kjell Van Royen; Hilde Brems; Eric Legius; Johan Lammens; Armand Laumen
Journal:  Eur J Pediatr       Date:  2016-08-12       Impact factor: 3.183

8.  Conservative management of neck and thoracic pain in an adult with neurofibromatosis-1.

Authors:  John Mignelli; Lauren J Tollefson; Eric Stefanowicz
Journal:  J Can Chiropr Assoc       Date:  2021-04

9.  New insights into osteogenic and chondrogenic differentiation of human bone marrow mesenchymal stem cells and their potential clinical applications for bone regeneration in pediatric orthopaedics.

Authors:  Nicola Giuliani; Gina Lisignoli; Marina Magnani; Costantina Racano; Marina Bolzoni; Benedetta Dalla Palma; Angelica Spolzino; Cristina Manferdini; Caterina Abati; Denise Toscani; Andrea Facchini; Franco Aversa
Journal:  Stem Cells Int       Date:  2013-05-23       Impact factor: 5.443

10.  Secondary Knee Osteoarthritis due to Neurofibromatosis Type 1 Treated with above the Knee Amputation: A Case Report.

Authors:  Jay Patel; Jeffrey Whiting; Daniel Jones
Journal:  Case Rep Orthop       Date:  2013-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.